<DOC>
	<DOCNO>NCT00047008</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy ( RT ) use high-energy x-rays damage tumor cell . Giving radiation therapy different way combine chemotherapy surgery may kill tumor cell . It yet know radiation therapy regimen combine chemotherapy without surgery effective head neck cancer . PURPOSE : Randomized phase III trial compare two different radiation therapy regimen combine cisplatin without surgery treating patient stage III stage IV head neck cancer .</brief_summary>
	<brief_title>Chemotherapy Radiation Therapy With Without Surgery Treating Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Compare overall survival patient stage III IV squamous cell carcinoma head neck treat conventional v accelerate radiotherapy concurrent cisplatin without surgical resection . Secondary - Compare local-regional control disease disease-free rate patient treat regimen . - Compare acute late toxicity regimens patient . - Compare quality life , perception side effect , performance status patient treat regimen . - Determine whether epidermal growth factor receptor cyclo-oxygenase-2 expression independent prognostic marker patient treat regimen . OUTLINE : This randomize , multicenter study . Patients stratify accord tumor site ( larynx v ) , nodal stage ( N0 vs N1 N2a N2b v N2c N3 ) , Zubrod performance status ( 0 vs 1 ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo standard fractionation radiotherapy 5 day week 7 week . Patients also receive cisplatin IV day 1 , 22 , 43 . - Arm II : Patients undergo accelerate fractionation radiotherapy 5 day week 3.5 week twice day , 5 day week , 2.5 week . Patients also receive cisplatin IV day 1 22 . Patients biopsy-proven relapse disease 3 month completion therapy undergo surgical resection primary tumor . Quality life assess baseline , one last 2 week treatment , 3 12 month , annually 4 year . Patients follow 6-8 week , every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A total 720 patient ( 360 per treatment arm ) accrue study within 3 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma oral cavity , oropharynx , hypopharynx , larynx Stage III IV ( T2 , N23 , M0 T34 , N , M0 ) No metastases clavicle distant clinical exam radiology PATIENT CHARACTERISTICS : Age 18 Performance status Zubrod 01 Life expectancy Not specify Hematopoietic Absolute granulocyte count least 2,000/mm^3 Platelet count least 100,000/mm^3 Hepatic Bilirubin great 1.5 mg/dL Alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) great 2 time upper limit normal Renal Creatinine great 1.5 mg/dL Creatinine clearance least 50 mL/min Calcium normal Cardiovascular No symptomatic coronary artery disease ( angina ) No myocardial infarction within past 6 month Other No invasive malignancy within past 3 year except nonmelanoma skin cancer No simultaneous primary tumor Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy head neck except radioactive iodine therapy Surgery No prior surgery primary tumor node except diagnostic biopsy nodal sample neck disease No radical modify neck dissection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
</DOC>